Program

12:00 Walk-in, registration and lunch
13:00 Word of welcome
13:10 Sjoerd van der Burg, Professor of Cancer Immunology & Therapy
13:40 Gerben Moolhuizen, CEO ISA Pharmaceuticals
14:00 Katka Franke, Associate Director Human Immunology Curevac
14:20 Coffee and tea break
14:50 Carl Figdor, Professor of Immunology
15:10 Erik Manting, CEO Mendus AB
15:30 Helen Lavender, Translational Scientist CRUK & Vaccitech Oncology Limited (VOLT)
15:50 Short break
16:05 Interactive session
16:35 Networking drinks
18:00 End